Hepatitis B virus infecties in Nederland: een inventariserend onderzoek

2.50
Hdl Handle:
http://hdl.handle.net/10029/256310
Title:
Hepatitis B virus infecties in Nederland: een inventariserend onderzoek
Authors:
Grosheide PM; Bosman A; Hattum J van; Lumey LH; Loon AM van
Other Titles:
Hepatitis B virus infections in the Netherlands: an inventory
Abstract:
Abstract niet beschikbaar

To determine the incidence of hepatitis B and possible trends since the introduction of the hepatitis B vaccine in the Netherlands, serologic and epidemiologic data pertaining to risk factors of disease acquisition were obtained. Recent studies from the United States showed that the current strategy for prevention of hepatitis B, which targets high-risk groups immunization, has failed to have a significant impact on the incidence of disease. This finding made reconsideration of the similar strategy for prevention of hepatitis B in the Netherlands necessary. Since the major means by which the status of infectious diseases are monitored in the Netherlands are limited the need for a more active surveillance system in order to accurately reflect the success of prevention, is stressed.
Issue Date:
31-Jul-1991
URI:
http://hdl.handle.net/10029/256310
Additional Links:
http://www.rivm.nl/bibliotheek/rapporten/119003001.html
Type:
Onderzoeksrapport
Language:
nl
Sponsors:
DGVGZ/AG
Appears in Collections:
RIVM official reports

Full metadata record

DC FieldValue Language
dc.contributor.authorGrosheide PM-
dc.contributor.authorBosman A-
dc.contributor.authorHattum J van-
dc.contributor.authorLumey LH-
dc.contributor.authorLoon AM van-
dc.date.accessioned2012-12-12T13:51:13Z-
dc.date.available2012-12-12T13:51:13Z-
dc.date.issued1991-07-31-
dc.identifier119003001-
dc.identifier.urihttp://hdl.handle.net/10029/256310-
dc.description.abstractAbstract niet beschikbaarnl
dc.description.abstractTo determine the incidence of hepatitis B and possible trends since the introduction of the hepatitis B vaccine in the Netherlands, serologic and epidemiologic data pertaining to risk factors of disease acquisition were obtained. Recent studies from the United States showed that the current strategy for prevention of hepatitis B, which targets high-risk groups immunization, has failed to have a significant impact on the incidence of disease. This finding made reconsideration of the similar strategy for prevention of hepatitis B in the Netherlands necessary. Since the major means by which the status of infectious diseases are monitored in the Netherlands are limited the need for a more active surveillance system in order to accurately reflect the success of prevention, is stressed.en
dc.description.sponsorshipDGVGZ/AG-
dc.format.extent78 p-
dc.language.isonl-
dc.relation.ispartofRIVM Rapport 119003001-
dc.relation.urlhttp://www.rivm.nl/bibliotheek/rapporten/119003001.html-
dc.subject04nl
dc.subject91-3nl
dc.subjecthepatitis bnl
dc.subjectincidentienl
dc.subjectprevalentienl
dc.subjectrisicogroepennl
dc.subjectvaccinatienl
dc.subjectsurveillancenl
dc.subjecthepatitis bnl
dc.subjectincidencenl
dc.subjectprevalencenl
dc.subjectrisk groupsnl
dc.subjectvaccinationnl
dc.subjectsurveilancenl
dc.titleHepatitis B virus infecties in Nederland: een inventariserend onderzoeknl
dc.title.alternativeHepatitis B virus infections in the Netherlands: an inventoryen
dc.typeOnderzoeksrapport-
dc.date.updated2012-12-12T13:51:14Z-
All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.